The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X
This study has been completed.
Sponsor:
National Heart and Lung Institute
Information provided by:
National Heart and Lung Institute
ClinicalTrials.gov Identifier:
NCT00123617
First received: July 21, 2005
Last updated: July 29, 2005
Last verified: May 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is designed to test the hypothesis that participation in a standard phase III group based cardiac rehabilitation programme will improve psychological morbidity, quality of life and cardiovascular risk factors, along with chest pain severity and frequency in women with cardiac syndrome X.
| Condition | Intervention | Phase |
|---|---|---|
|
Microvascular Angina |
Procedure: Phase III group based cardiac rehabilitation |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Impact of Cardiac Rehabilitation on Angina Frequency, Psychological Morbidity and Quality of Life in Women With Syndrome X |
Resource links provided by NLM:
Further study details as provided by National Heart and Lung Institute:
Primary Outcome Measures:
- Anxiety
- Depression
- Health anxiety
- Cardiac anxiety
- Quality of life
- Symptom severity
- Symptom frequency
Secondary Outcome Measures:
- Cardiovascular risk factors
- Physical ability
- Time to pain
| Estimated Enrollment: | 64 |
| Study Start Date: | January 2003 |
| Estimated Study Completion Date: | March 2004 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 30 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Women
- Aged 30 to 80 years
- Postmenopausal > 1 year since last menstrual period
- Angiographically normal coronary arteries
- Positive treadmill exercise test for myocardial ischemia
- Reported angina pectoris > 2 episodes per week
- Diagnosis > 6 months
- Willing to give written informed consent
Exclusion Criteria:
- History of psychiatric illness
- History of any other chronic illness
- Participation in another research study within the previous 60 days
- Suffer any physical condition for which exercise is a contra-indication.
- Unwilling to give written informed consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00123617
Locations
| United Kingdom | |
| National Heart and Lung Institute, Imperial College London | |
| London, United Kingdom, SW3 6LY | |
Sponsors and Collaborators
National Heart and Lung Institute
Investigators
| Principal Investigator: | Peter Collins, MD FRCP | National Heart and Lung Institute, Imperial College London |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00123617 History of Changes |
| Other Study ID Numbers: | 02-239 |
| Study First Received: | July 21, 2005 |
| Last Updated: | July 29, 2005 |
| Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Keywords provided by National Heart and Lung Institute:
|
Chest pain Women Syndrome X |
Cardiac rehabilitation Psychological morbidity Cardiovascular risk factors |
Additional relevant MeSH terms:
|
Angina Pectoris Microvascular Angina Myocardial Ischemia Heart Diseases Cardiovascular Diseases |
Vascular Diseases Chest Pain Pain Signs and Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013